tiprankstipranks
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Hong Kong Market

China Shineway Pharmaceutical Group Limited (2877) Income Statement

Compare
0 Followers

China Shineway Pharmaceutical Group Limited Income Statement

Last quarter (Q4 2023), China Shineway Pharmaceutical Group Limited's total revenue was ¥2.12B, an increase of 26.86% from the same quarter last year. In Q4, China Shineway Pharmaceutical Group Limited's net income was ¥478.05M. See China Shineway Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 4.52B¥ 3.95B¥ 3.22B¥ 2.66B¥ 2.71B
Gross Profit
¥ 3.39B¥ 2.94B¥ 2.41B¥ 1.99B¥ 1.98B
Operating Expenses
¥ 2.42B¥ 2.12B¥ 1.79B¥ 1.71B¥ 1.46B
Depreciation and Amortization
¥ 177.10M¥ 185.86M¥ 182.39M¥ 208.41M¥ 204.98M
EBITDA
¥ 1.42B¥ 1.10B¥ 903.74M¥ 620.04M¥ 672.71M
Operating Income
¥ 975.53M¥ 713.58M¥ 534.37M¥ 422.40M¥ 476.48M
Other Income/Expenses
¥ 264.72M¥ 203.45M¥ 185.74M¥ -27.37M¥ 166.29M
Pretax Income
¥ 1.24B¥ 917.02M¥ 720.10M¥ 395.02M¥ 642.77M
Net Income
¥ 969.51M¥ 722.77M¥ 556.67M¥ 295.03M¥ 503.15M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 1.28¥ 0.96¥ 0.74¥ 0.39¥ 0.64
Diluted EPS
¥ 1.28¥ 0.96¥ 0.74¥ 0.39¥ 0.64
Weighted Average Shares Outstanding
755.40M 755.40M 755.14M 756.49M 780.82M
Weighted Average Shares Outstanding (Diluted)
755.40M 755.40M 755.14M 756.75M 780.95M
Currency in CNY

China Shineway Pharmaceutical Group Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis